Posters

Trabecular micro-bypass implantation with iStent inject® combined with cataract surgery: Saudi experience

Poster Details

First Author: A.Al Habash SAUDI ARABIA

Co Author(s):    W. Otaif                    

Abstract Details

Purpose:

To evaluate 2nd-generation trabecular micro-bypass stents (iStent inject®) combined with cataract surgery in eyes with open-angle glaucoma (OAG) in a Saudi patients. Such data are especially valuable given iStent inject’s relatively recent introduction in Saudi Arabia

Setting:

Surgery performed by a single surgeon across multiple hospitals in Saudi Arabia

Methods:

Retrospective consecutive case series of primarily POAG patients (902%) who underwent iStent inject implantation with phacoemulsification cataract surgery. Efficacy measures consisted of mean intraocular pressure (IOP), mean number of medications, and safety outcomes. Reported here are early-term findings with the intent of augmenting the dataset with additional patients and longer-term follow-up.

Results:

30 eyes were successfully implanted with iStent inject combined with phaco. Preoperative mean IOP was 18.4±2.7 mmHg on 2.3±1.2 mean medications (range 1-4 medications). Day 1 mean postop IOP (n=29) was 13.7±3.1 mmHg. Mean IOP was ~15 mmHg at Weeks 1 (n=27), 4 (n=23), and 12 (n=16) postop. Week-4 average number of meds is 0.2±0.5 with all but one eye medication-free. Favorable safety was observed with no intraoperative or postoperative complications reported.

Conclusions:

This real-world iStent inject dataset demonstrated substantial early-term IOP and medication reductions with the majority eyes free of medication. To our knowledge, this is the first report of outcomes in a Saudi patient population with OAG. This efficacy was accompanied by favorable safety, reinforcing current literature on the durable and safe performance of iStent inject in glaucoma.

Financial Disclosure:

None